Mutations in FAT1 and KEAP1 generated several complex tumor antigens and higher TMB, but as the expression of many immune-related genes was significantly lower, it may lead to immune escape or poor efficacy of ICBs. This evidence concerns the gene FAT1 and neoplasm.